Effects of Pantoprazole on serum glucose level in type two diabetic patients
Not Applicable
- Conditions
- Type 2 diabetes.Endocrine, nutritional and metabolic diseases
- Registration Number
- IRCT2013070713612N2
- Lead Sponsor
- Research deputy of Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inclusion criteria : type II diabetes and oral blood glucose lowering drugs for at least 5 years; HbA1C level<8.5 percent; willing to participate in the study
Exclusion Criteria
Presence of diabetic complications; use of insulin in the week before the study and during the study; pregnancy and lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma glucose levels. Timepoint: Before and 12 weeks after intervention. Method of measurement: Paraclinical.;Serum gastrtin levels. Timepoint: Before and 12 weeks after intervention. Method of measurement: Paraclinical.;HbA1C. Timepoint: Before and 12 weeks after intervention. Method of measurement: Paraclinical.;Serum insulin levels. Timepoint: Before and 12 weeks after intervention. Method of measurement: Paraclinical.
- Secondary Outcome Measures
Name Time Method